Navigation Links
MicroConstants China Receives Endorsement of OECD GLP Compliance
Date:5/26/2011

BEIJING, May 26, 2011 /PRNewswire/ -- MicroConstants China Inc., a Contract Research Organization (CRO) conducting preclinical pharmacokinetics studies and providing full-service early stage clinical trial management in Beijing, announces the Endorsement of Compliance with the OECD Principles of Good Laboratory Practice (GLP) in the areas of analytical chemistry and pharmacokinetic studies from the Netherlands GLP Compliance Monitoring Programme. MicroConstants China is the first test facility in China to receive an Endorsement of GLP Compliance from the Netherlands inspectorate.

Dr. Q. David Yang, chief executive officer of MicroConstants China, is thrilled with the OECD Endorsement of GLP Compliance. "The Endorsement illustrates our commitment to quality and validates our bioanalytical laboratory's capability of carrying out method validation and bioanalysis under OECD Principles of GLP."

MicroConstants China received the Endorsement on May 23, 2011 following a one week assessment and onsite inspection conducted by the Netherlands GLP Compliance Monitoring Programme in early 2011. Late last year, they also received ISO-17025 accreditation from the China National Accreditation Service for Conformity Assessment (CNAS). These accomplishments can be attributed to MicroConstants San Diego's quality systems, which MicroConstants China adopted and successfully implemented at the Beijing laboratory in 2009.

"This Endorsement, along with the CNAS accreditation achieved last year, demonstrates that our Beijing team is capable of conducting high quality contract research services equivalent to those provided by our San Diego bioanalytical laboratory," said Dr. Gilbert Lam, co-founder of MicroConstants China and president of MicroConstants, Inc. in San Diego, California. "This is a significant accomplishment and we are very proud of their progress."

About MicroConstants China Inc.

MicroConstants China Inc. is a Contract Research Organization (CRO) that was established in 2007 by the founder and president of MicroConstants, Inc., a bioanalytical and PK specialty CRO in San Diego, California with over a decade of GLP compliance history. Located in Beijing, MicroConstants China provides preclinical and clinical pharmacokinetic analysis and early stage clinical trial management services, including clinical site qualification, trial monitoring, data management, biostatistics, and clinical summary reports to pharmaceutical and biotech companies worldwide. Additionally, the CRO offers QA audit and drug development project management services for preclinical toxicology and pharmacology studies in China. Its bioanalytical laboratory is fully GLP-compliant with USFDA, OECD, Japan MHLW and China SFDA guidelines. For more information about MicroConstants China and the contract research services they provide, please visit http://www.microconstants.com/china.


'/>"/>
SOURCE MicroConstants China Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. MicroConstants Celebrates National Chemistry Week by Teaching San Diego High School Students About the Drug Development Process
2. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results
3. China Sky One Medical, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
4. China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
5. China Bionanometer Industries Corporation Promotes New Product Beauty Look in China
6. China Biologic Products Announces Second Quarter 2008 Results Conference Call
7. China Medicine Announces Strong Second Quarter 2008 Results
8. China Biologic Products Establishes Governance and Nominating Committee and Compensation Committee
9. China Bio Energy Holdings Group Reports Second Quarter 2008 Financial Results
10. China Sky One Medical, Inc. Develops Nasal Spray for Rheumatic Disease
11. China-Biotics, Inc. Reports First Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2017)... ... June 22, 2017 , ... For the months ... produced a Spotlight series on “Cell Therapy Regulation” for its regenerative ... experts on the unique regulatory challenges of stem cell medical research. , Stem ...
(Date:6/22/2017)... , ... June 22, 2017 , ... ... announced the release of Limfinity® version 6.5, a content-packed update to the Limfinity® ... to gain a larger and more diverse base of customers among labs and ...
(Date:6/20/2017)... ... , ... Biologist Dawn Maslar MS has found a biomarker that she claims ... Choose: The Neuroscience of Meeting, Dating, Losing Your Mind, and Finding True Love, Maslar ... next step, in my estimation, was to scientifically track the evidence of commitment in ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... a well-versed leader with extensive assay development and biomarker expertise, as VP of ... a Boston CRO specializing in bio-analytical assay development and sample testing services. The ...
Breaking Biology Technology:
(Date:3/24/2017)... , March 24, 2017 The Controller General of ... Mr. Abdulla Algeen have received the prestigious international IAIR Award ... Continue Reading ... ... and Deputy Controller Abdulla Algeen (small picture on the right) have received ...
(Date:3/22/2017)...   Neurotechnology , a provider of high-precision ... the release of the SentiVeillance 6.0 ... recognition using up to 10 surveillance, security and ... new version uses deep neural-network-based facial detection and ... a Graphing Processing Unit (GPU) for enhanced speed. ...
(Date:3/20/2017)... 20, 2017 PMD Healthcare announces the release ... Wellness Management System (WMS), a remote, real-time lung health ... PMD Healthcare is a Medical Device, Digital Health, and ... to creating innovative solutions that empower people to improve ... focus, PMD developed the first ever personal spirometer, Spiro ...
Breaking Biology News(10 mins):